Publications

Latest publication 02/01/2025

ART26-12- a novel fatty acid-binding protein 5 inhibitor- shows efficacy in mult

Our previous OIPN study showed that ART26.12 primarily exerted its analgesic effect via CB1, with involvement from CB2, TRPV1 and PPARα (Warren...

Array
(
    [id_prestablog_news] => 2018
    [id_shop] => 1
    [date] => 2025-02-01 00:00:00
    [date_modification] => 2025-02-01 00:00:00
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 3701
    [id_lang] => 1
    [title] => ART26-12- a novel fatty acid-binding protein 5 inhibitor- shows efficacy in mult
    [paragraph] => ART26-12- a novel fatty acid-binding protein 5 inhibitor- shows efficacy in multiple preclinical neuropathy models
    [content] => 
Authors
W. G. Warren, M. Osborn, A. David-Pereira, C. Tsantoulas, Wenwen Xue, A. Yates, S. E. OSullivan

 Lab

Journal
European Journal of Pain
Abstract
Our previous OIPN study showed that ART26.12 primarily exerted its analgesic effect via CB1, with involvement from CB2, TRPV1 and PPARα (Warren et al.,2024). While antagonist experiments and lipidomics were not conducted in the current study, it is likely that ART26.12 mediated its effects in these neuropathic pain models through similar mechanisms. Other cannabinoid agonists have produced CB1-dependent analgesia in platinum-based CIPN models (Bagher et al.,2023; Deng, Cornett, et al.,2015; Deng, Guindon, et al.,2015; Mulpuri et al.,2018; Pascual et al.,2005; Rahn et al.,2014; Sepulveda et al.,2022; Vera et al.,2013). Similarly, CB1- and CB2-dependent analgesia has been shown in diabetic neuropathy and cancer-induced bone pain, as well as PIPN (Deng et al.,2012; Gonçalves et al.,2022; Lin et al.,2022; Lozano-Ondoua et al.,2010,2013; Toniolo et al.,2022; Xu et al.,2014; Zeng et al.,2024; Zhang et al.,2018). TRPV1 and the wider eCB system are therapeutic targets in these pathologies (de Almeida et al.,2021; Liu et al.,2023; Rossato et al.,2018; Sun et al.,2019; Thompson et al.,2020; Xie et al.,2022; Zhang et al.,2019). Finally,N-arachidonoyl-glycine, a lipid previously shown to be elevated by ART26.12 (Warren et al.,2024), showed analgesic effects in a preclinical neuropathy model (Vuong et al.,2008). While these studies demonstrate a common mechanism of action across different neuropathies, activation of the eCB system also mediates analgesia in a wide variety of pain models. For example, FABP5 inhibition or knockdown produces CB1-dependent analgesia in inflammatory pain, osteoarthritis and chronic constriction injury (Berger et al.,2012; Bogdan et al.,2018,2022; Fauzan et al.,2022; Gordon et al.,2024; Kaczocha et al.,2014,2015; Peng et al.,2017; Yan et al.,2018; Zhu et al.,2023). Overall, this suggests that ART26.12 may also have therapeutic potential in chronic pain conditions with an inflammatory component.
Keywords/Topics
allodynia; neuropathy
BIOSEB Instruments Used:
Electronic Von Frey - Wireless (BIO-EVF-WRS),Electronic Von Frey 5 with embedded camera (BIO-EVF5)
    [meta_description] => 
    [meta_keywords] => https://onlinelibrary.wiley.com/doi/abs/10.1002/ejp.4718
    [meta_title] => 
    [link_rewrite] => ART26-12--a-novel-fatty-acid-binding-protein-5-inhibitor--shows-efficacy-in-multiple-preclinical-neuropathy-models
    [actif_langue] => 1
    [read] => 15
    [count_comments] => 0
    [id] => 2018
    [categories] => Array
        (
            [29] => Array
                (
                    [id_prestablog_categorie] => 29
                    [title] => Neuropathic pain
                    [link_rewrite] => Neuropathic-pain
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => ART26-12- a novel fatty acid-binding protein 5 inhibitor- shows efficacy in multiple [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [1859] => Array
                (
                    [name] => Electronic Von Frey - Wireless
                    [description_short] => 
A quick solution to determine the mechanical sensitivity threshold in rodents (mice and rats). Now wireless, to be free from annoying cables!

This precise and easy-to-use electronic instrument is a must-have reference for your research in analgesia, nociception, neuro-pathologies and post-operative pain.

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/pain-mechanical-allodynia-hyperalgesia/1859-electronic-von-frey-4.html
                )

            [1860] => Array
                (
                    [name] => Electronic Von Frey 5 with embedded camera
                    [description_short] => 
As an electronic version of the classical Von Frey Filaments esthesiometer (or aesthesiometer), the latest evolution of Bioseb's Electronic Von Frey instrument for determining the mechanical sensitivity threshold in rodents (rats and mice) is a must-have instrument for your reseach on hyperalgesia and allodynia. By measuring and recording the force at which the animal exhibits a paw withdrawal reflex, pathologies related to sensory response and hyper- or hypo-aesthesia can be studied.

The EVF5 includes an embedded camera inside the stimulator handle and a new, dedicated software revolutionizing the experimental process.

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/pain-mechanical-allodynia-hyperalgesia/1860-electronic-von-frey-5-with-embedded-camera.html
                )

        )

)
1